Characterization of antibodies that selectively detect α-synuclein in pathological inclusions

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Acta Neuropathologica

• Publication date

  2008-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00401-008-0375-1PMID 18414880PMCID PMC2664556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.

  2007cited by this paper
• Presynaptic α-Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies

  2007cited by this paper
• Neuronal !-Synucleinopathy with Severe Movement Disorder in Mice Expressing A 53 T Human !-Synuclein

  2007cited by this paper
• Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.

  2006cited by this paper
• Cytosolic Catechols Inhibit α-Synuclein Aggregation and Facilitate the Formation of Intracellular Soluble Oligomeric Intermediates

  2006cited by this paper
• Nosology of Parkinson's disease: looking for the way out of a quagmire.

  2005cited by this paper
• The E46K mutation in alpha-synuclein increases amyloid fibril formation.

  2005cited by this paper
• The E46K Mutation in α-Synuclein Increases Amyloid Fibril Formation*

  2005cited by this paper
• Mutation E46K increases phospholipid binding and assembly into filaments of human α‐synuclein

  2004cited by this paper
• Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein.

  2004cited by this paper
• The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

  2004cited by this paper
• Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.

  2004cited by this paper
• Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?

  2004cited by this paper
• Does α‐synuclein modulate dopaminergic synaptic content and tone at the synapse?

  2004cited by this paper
• Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications

  2004cited by this paper
• α-synuclein locus duplication as a cause of familial Parkinson's disease

  2004cited by this paper
• Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications.

  2004cited by this paper
• Is the Initial Insult in Parkinson's Disease and Dementia with Lewy Bodies a Neuritic Dystrophy?

  2003cited by this paper
• Are ubiquitination pathways central to Parkinson's disease?

  2003influential reference
• Pathology and Neurotransmitter Abnormalities of Dementia with Lewy Bodies

  2003cited by this paper
• A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114

  2003cited by this paper
• alpha-Synuclein locus triplication causes Parkinson's disease.

  2003cited by this paper
• α-Synuclein Locus Triplication Causes Parkinson's Disease

  2003cited by this paper
• Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies.

  2002cited by this paper
• Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice

  2002cited by this paper
• Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases

  2002influential reference
• Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.

  2002cited by this paper
• Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.

  2002cited by this paper
• Prominent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neurons.

  2001cited by this paper
• The synucleins

  2001cited by this paper
• Induction of alpha-synuclein aggregation by intracellular nitrative insult.

  2001cited by this paper
• Prominent Perikaryal Expression of α- and β-Synuclein in Neurons of Dorsal Root Ganglion and in Medullary Neurons

  2001cited by this paper
• A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly*

  2001influential reference
• Induction of α-Synuclein Aggregation by Intracellular Nitrative Insult

  2001cited by this paper
• Alpha-synuclein and neurodegenerative diseases

  2001influential reference
• Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.

  2000cited by this paper
• Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease

  2000cited by this paper
• Distinctive neuropathology revealed by α-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p

  2000cited by this paper
• Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson’s disease?

  2000cited by this paper
• Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

  2000cited by this paper
• Immunohistochemical and Biochemical Studies Demonstrate a Distinct Profile of α‐Synuclein Permutations in Multiple System Atrophy

  2000cited by this paper
• Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions.

  2000cited by this paper
• PAN, the proteasome-activating nucleotidase from archaebacteria, is a protein-unfolding molecular chaperone

  2000cited by this paper
• Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies.

  2000cited by this paper
• Dityrosine Cross-linking Promotes Formation of Stable α-Synuclein Polymers

  2000cited by this paper
• Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson’s disease

  2000cited by this paper
• Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation.

  2000cited by this paper
• A panel of epitope‐specific antibodies detects protein domains distributed throughout human α‐synuclein in lewy bodies of Parkinson's disease

  2000influential reference
• Dementia with Lewy bodies.

  1999cited by this paper
• Mutant and Wild Type Human α-Synucleins Assemble into Elongated Filaments with Distinct Morphologies in Vitro *

  1999cited by this paper
• Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation*

  1999cited by this paper
• Widespread alterations of alpha-synuclein in multiple system atrophy.

  1999cited by this paper
• Dementia with Lewy bodies

  1999cited by this paper
• Widespread Alterations of α-Synuclein in Multiple System Atrophy

  1999cited by this paper
• α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies

  1998cited by this paper
• Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein

  1998cited by this paper
• alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

  1998cited by this paper
• AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

  1998cited by this paper
• Synthetic filaments assembled from C-terminally truncated alpha-synuclein.

  1998cited by this paper
• Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

  1998cited by this paper
• Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies

  1998cited by this paper
• Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

  1998cited by this paper
• Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

  1998cited by this paper
• Synthetic filaments assembled from C‐terminally truncated α‐synuclein

  1998cited by this paper
• Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

  1998cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• α-Synuclein in Lewy bodies

  1997cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

  1997cited by this paper
• Neocortical Lewy Body Counts Correlate with Dementia in the Lewy Body Variant of Alzheimer's Disease

  1996cited by this paper
• Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies.

  1991cited by this paper
• Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.

  1989cited by this paper
• The prevention of acute gastric ulcer in the rat by alpha-methyldopa.

  1967cited by this paper
• Parkinsonism

  1967cited by this paper

• The pesticide chlorpyrifos increases the risk of Parkinson’s disease

  2025cites this paper
• Unveiling the Cutting Edge: Recent Developments in α-Synuclein Nano-biosensor Technology for Precision Diagnosis of Parkinson’s Disease

  2025cites this paper
• Differential role of C-terminal truncations on alpha-synuclein pathology and Lewy body formation

  2025cites this paper
• Development of an 18F-labeled azobenzothiazole tracer for α-synuclein aggregates in the brain.

  2024cites this paper
• Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases

  2023influential citation
• Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies

  2022cites this paper
• Evaluation of an Adoptive Cellular Therapy-Based Vaccine in a Transgenic Mouse Model of α-synucleinopathy

  2022cites this paper
• Neighbouring modifications interfere with the detection of phosphorylated alpha-synuclein at Serine 129: Revisiting the specificity of pS129 antibodies

  2022cites this paper
• Compact Luminol Chemiluminophores for In Vivo Detection and Imaging of β-Sheet Protein Aggregates.

  2022cites this paper
• Inhibition of α-Synuclein Seeding-Dependent Aggregation by ssDNA Aptamers Specific to C-Terminally Truncated α-Synuclein Fibrils.

  2022cites this paper
• Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity

  2022cites this paper
• In vivo aggregation of presynaptic alpha-synuclein is not influenced by its phosphorylation at serine-129

  2021cites this paper
• Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model

  2021cites this paper
• Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential

  2021cites this paper
• Age-related increase of alpha-synuclein oligomers is associated with motor disturbances in L61 transgenic mice

  2021cites this paper
• Investigating the presence of doubly phosphorylated α‐synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases

  2020cites this paper
• Snca-GFP Knock-In Mice Reflect Patterns of Endogenous Expression and Pathological Seeding

  2020cites this paper
• Nigral overexpression of α‐synuclein in a rat Parkinson’s disease model indicates alterations in the enteric nervous system and the gut microbiome

  2020cites this paper
• Parkinsonian GM2 synthase knockout mice lacking mature gangliosides develop urinary dysfunction and neurogenic bladder

  2019cites this paper
• Slow Progressive Accumulation of Oligodendroglial Alpha-Synuclein (α-Syn) Pathology in Synthetic α-Syn Fibril-Induced Mouse Models of Synucleinopathy.

  2019cites this paper
• Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular α-synuclein transfer.

  2019cites this paper
• Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.

  2019cites this paper
• Antibodies against alpha‐synuclein: tools and therapies

  2019cites this paper
• The center of olfactory bulb‐seeded α‐synucleinopathy is the limbic system and the ensuing pathology is higher in male than in female mice

  2019cites this paper
• Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models.

  2019cites this paper
• Structural Remodeling of Alpha-Synuclein by Small Molecules: A Novel Path to Neuroprotective Therapeutics

  2018cites this paper
• Induction of the Immunoproteasome Subunit Lmp7 Links Proteostasis and Immunity in α-Synuclein Aggregation Disorders

  2018cites this paper
• Localized Induction of Wild-Type and Mutant Alpha-Synuclein Aggregation Reveals Propagation along Neuroanatomical Tracts

  2018cites this paper
• Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions

  2018cites this paper
• The Influence of Age, Gender, and Thiol Repletion in an In Vivo Model of Lewy Body Disorders

  2018cites this paper
• Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by Glucosylceramide.

  2018cites this paper
• Proteolysis of α‐synuclein fibrils in the lysosomal pathway limits induction of inclusion pathology

  2017cites this paper
• Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course.

  2017cites this paper
• The ER retention protein RER1 promotes alpha-synuclein degradation via the proteasome

  2017cites this paper
• Progression of alpha‐synuclein pathology in multiple system atrophy of the cerebellar type

  2017cites this paper
• Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration

  2017cites this paper
• A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies

  2017cites this paper
• Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity

  2017cites this paper
• Comparison of the in vivo induction and transmission of &agr;-synuclein pathology by mutant &agr;-synuclein fibril seeds in transgenic mice

  2017cites this paper
• Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion‐like behaviour of alpha‐synuclein

  2016cites this paper
• Robust Central Nervous System Pathology in Transgenic Mice following Peripheral Injection of α-Synuclein Fibrils

  2016cites this paper
• Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity.

  2016cites this paper
• Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice

  2015cites this paper
• Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.

  2015cites this paper
• Studies of lipopolysaccharide effects on the induction of α-synuclein pathology by exogenous fibrils in transgenic mice

  2015cites this paper
• Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies

  2015cites this paper
• The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models.

  2014cites this paper
• Abrogation of α-synuclein–mediated dopaminergic neurodegeneration in LRRK2-deficient rats

  2014cites this paper
• Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.

  2014cites this paper
• Brain Injection of α-Synuclein Induces Multiple Proteinopathies, Gliosis, and a Neuronal Injury Marker

  2014cites this paper
• Neuropathology of Parkinson’s Disease

  2014cites this paper
• Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys

  2014cites this paper
• The role of alpha-synuclein phosphorylation in synucleinopathies

  2014cites this paper
• Anticorps anti-alpha-synucléine et leurs méthodes d'utilisation

  2014cites this paper
• Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice

  2014cites this paper
• Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice

  2014cites this paper
• Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein

  2013cites this paper
• Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy

  2013cites this paper
• Pathogenesis of neurodegenerative diseases via templated recruitment

  2013cites this paper
• Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice

  2012cites this paper
• Probing and Trapping a Sensitive Conformation: Amyloid-β Fibrils, Oligomers, and Dimers

  2012cites this paper
• Soluble-SynucleinIsaNovelModulatorofAlzheimer's DiseasePathophysiology

  2012cites this paper
• An antibody with high reactivity for disease-associated a-synuclein reveals extensive brain pathology Gabor G. KovacsUta WagnerBenoit DumontMaria PikkarainenAwad A. Osman • Nathalie StreichenbergerIrene LeisserJeremy VerchereThierry BaronIrina Alafuzoff •

  2012cites this paper
• The role of α-synuclein in neurodegeneration — An update

  2012cites this paper
• Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts

  2012cites this paper
• An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology

  2012cites this paper
• Soluble α-Synuclein Is a Novel Modulator of Alzheimer's Disease Pathophysiology

  2012cites this paper
• Studies of protein aggregation in A53T α-synuclein transgenic, Tg2576 transgenic, and P246L presenilin-1 knock-in cross bred mice.

  2012cites this paper
• Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice

  2012cites this paper
• E46K Human α-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment*

  2011cites this paper
• Characterization of kinases involved in the phosphorylation of aggregated α‐synuclein

  2011cites this paper
• Non-Dopaminergic Pathology of Parkinson's Disease

  2011cites this paper
• Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.

  2010cites this paper
• Production of a monoclonal antibody, against human α-synuclein, in a subpopulation of C57BL/6J mice, presenting a deletion of the α-synuclein locus.

  2010cites this paper
• DJ-1 deficient mice demonstrate similar vulnerability to pathogenic Ala53Thr human alpha-syn toxicity.

  2010cites this paper
• Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes.

  2010cites this paper
• roduction of a monoclonal antibody , against human-synuclein , in a ubpopulation of C 57 BL / 6 J mice , presenting a deletion of the-synuclein locus nne -

  2010influential citation
• A novel, high‐efficiency cellular model of fibrillar α‐synuclein inclusions and the examination of mutations that inhibit amyloid formation

  2010cites this paper
• Molecular mechanisms of alpha-synuclein neurodegeneration.

  2009cites this paper
• Anticorps humains anti-alpha-synucléine

  2009cites this paper
• Menschliche anti-alpha-synuclein-autoantikörper

  2009cites this paper
• Mitochondrial inhibitor 3‐nitroproprionic acid enhances oxidative modification of alpha‐synuclein in a transgenic mouse model of multiple system atrophy

  2009cites this paper
• Formation and development of Lewy pathology: a critical update

  2009cites this paper